Virbac SA (0NM7.IL)
- Previous Close
311.75 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 399.00 - Volume
0 - Avg. Volume
625 - Market Cap (intraday)
2.657B - Beta (5Y Monthly) 0.90
- PE Ratio (TTM)
22.28 - EPS (TTM)
13.99 - Earnings Date May 13, 2025
- Forward Dividend & Yield 1.32 (0.52%)
- Ex-Dividend Date Jun 26, 2023
- 1y Target Est
--
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
corporate.virbac.com5,386
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0NM7.IL
View MorePerformance Overview: 0NM7.IL
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0NM7.IL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0NM7.IL
View MoreValuation Measures
Market Cap
2.61B
Enterprise Value
2.77B
Trailing P/E
17.98
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.87
Price/Book (mrq)
2.50
Enterprise Value/Revenue
1.98
Enterprise Value/EBITDA
10.03
Financial Highlights
Profitability and Income Statement
Profit Margin
9.87%
Return on Assets (ttm)
8.00%
Return on Equity (ttm)
13.80%
Revenue (ttm)
1.21B
Net Income Avi to Common (ttm)
119.2M
Diluted EPS (ttm)
13.99
Balance Sheet and Cash Flow
Total Cash (mrq)
224.3M
Total Debt/Equity (mrq)
18.78%
Levered Free Cash Flow (ttm)
68.55M